I'ROM GROUP CO., LTD.

Other languages I'rom Group Co., Ltd.

Equities

2372

JP3105170009

Market Closed - Japan Exchange Other stock markets 07:00:00 01/07/2024 BST			5-day change	1st Jan Change
2,766 ^JPY	-0.04%		+0.22%	+37.68%

05-31	GenoDive Pharma Inc announced that it has received funding from I'rom Group Co., Ltd.	CI
2023	I'rom Group Co., Ltd. Reports Earnings Results for the Full Year Ended March 31, 2023	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

I'rom Group Co., Ltd. Reports Earnings Results for the Full Year Ended March 31, 2023	11/05/23
Lupin Ties Up with I'rom Group to Commercialize Denosumab in Japan	25/08/22
Lupin and I'rom Enter into an Exclusive Licensing Agreement for Denosumab Biosimilar for Japan	25/08/22
I'rom Group Co., Ltd. Announces Dividend for the Fiscal Year Ended March 31, 2021, Payable June 29, 2021 and Provided Dividend Guidance for the Second Quarter and Fiscal Year 2022	10/05/21
I'rom Group Co., Ltd. Reports Consolidated Earnings Results for the Six Months Ended September 30, 2017; Provides Earnings Guidance for the Fiscal Year Ending March 2018; Declares Dividend for the Second Quarter of Fiscal 2018, Payable on December 15, 2017	08/11/17
I'rom Group Co., Ltd. Reports Consolidated Earnings Results for the First Quarter Ended June 30, 2017; Provides Earnings Guidance for the Year Ending March 31, 2018	08/08/17
I'rom Group Co., Ltd. Reports Consolidated and Non-Consolidated Earnings Results for the Full Year Ended March 31, 2017; Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2018	11/05/17

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Secure and Increase the Performance of your Investments with our Team of Experts at your Side

Securing my Investments

fermer